The constant activation of the complement system, in the DM context, might be due to the production of advanced glycation end-products (AGE) and generation of neoepitopes by the hyperglycaemic environment and their interaction with MBL and MASPs. The gene discussed is MBL2; the disease is diabetes mellitus.